Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial

Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-18T23:46:58.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The record for the Marzeptacog Alfa trial is displayed with its study design, participant criteria, treatment details, outcomes, and research locations. It indicates the study was terminated by company decision and is no longer recruiting participants.
    Difference
    48%
    Check dated 2026-11-11T23:17:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 on a page showing a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T22:37:07.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-21T22:37:54.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-14T22:39:18.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the page remained on a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T22:51:43.000Z thumbnail image

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.